Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 3116

1.

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study.

Iemitsu K, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Obana M, Sasai N, Kaneshige H, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I.

J Clin Med Res. 2016 May;8(5):373-8. doi: 10.14740/jocmr2492w. Epub 2016 Mar 20.

2.

Canagliflozin (Invokana) for Type 2 Diabetes Mellitus [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Sep.

3.

Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.

Lam KS, Chow CC, Tan KC, Ma RC, Kong AP, Tong PC, Tsang MW, Chan TM, Tang SC, Lee KK, So WY, Tomlinson B.

Curr Med Res Opin. 2016 Apr 4:1-12. [Epub ahead of print]

PMID:
26933918
4.

Converting U-500 regular insulin to insulin detemir and insulin lispro in a patient undergoing dietary changes in preparation for bariatric surgery.

Nguyen KV, Weidner JA, Shaw KF, Valdez CA.

Am J Health Syst Pharm. 2016 Mar 1;73(5):292-7. doi: 10.2146/ajhp150378.

PMID:
26896501
5.

A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: A randomized placebo-controlled double-blind study.

Hu Y, Zhou X, Liu P, Wang B, Duan DM, Guo DH.

Complement Ther Med. 2016 Feb;24:13-8. doi: 10.1016/j.ctim.2015.11.005. Epub 2015 Dec 2.

PMID:
26860796
6.

Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats.

Akcilar R, Kocak FE, Simsek H, Akcilar A, Bayat Z, Ece E, Kokdasgil H.

Bratisl Lek Listy. 2016;117(2):100-5.

PMID:
26830041
7.

Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes.

Omotosho P, Mor A, Shantavasinkul PC, Corsino L, Torquati A.

Surg Endosc. 2016 Jan 28. [Epub ahead of print]

PMID:
26823053
8.
9.

Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.

Hu H, Xu M, Qi R, Wang Y, Wang C, Liu J, Luo L, Xia L, Fang Z.

Int J Clin Exp Med. 2015 Oct 15;8(10):17902-11. eCollection 2015.

10.

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.

Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I.

J Clin Med Res. 2016 Feb;8(2):116-25. doi: 10.14740/jocmr2417w. Epub 2015 Dec 28. Erratum in: J Clin Med Res. 2016 Mar;8(3):267.

11.

Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.

Scheen AJ.

Expert Rev Clin Pharmacol. 2016 Mar;9(3):385-99. doi: 10.1586/17512433.2016.1141046. Epub 2016 Feb 6.

PMID:
26761217
12.

[Mechanisms of the role of fibroblast growth factor 21 in attenuating insulin resistance].

Xu TY, Wang WF, Xu PF, Yuan QY, Liu SQ, Zhnag T, Ren GP, Li DS.

Yao Xue Xue Bao. 2015 Sep;50(9):1101-6. Chinese.

PMID:
26757545
13.

Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance.

Molina MN, Ferder L, Manucha W.

Curr Hypertens Rep. 2016 Jan;18(1):1. doi: 10.1007/s11906-015-0615-4.

PMID:
26694820
14.

[Significance of the regulation of hyperglucagonemia in type 2 diabetes mellitus].

Miuchi M, Miyagawa J, Namba M.

Nihon Rinsho. 2015 Dec;73(12):1988-94. Japanese.

PMID:
26666142
15.

Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.

Rhee KJ, Lee CG, Kim SW, Gim DH, Kim HC, Jung BD.

Int J Med Sci. 2015 Nov 23;12(12):987-94. doi: 10.7150/ijms.13339. eCollection 2015.

16.

Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.

Daltro PS, Alves PS, Castro MF, Azevedo CM, Vasconcelos JF, Allahdadi KJ, de Freitas LA, de Freitas Souza BS, Dos Santos RR, Soares MB, Macambira SG.

BMC Cardiovasc Disord. 2015 Dec 3;15:162. doi: 10.1186/s12872-015-0154-6.

17.
18.

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.

Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, Horowitz M, Rayner CK.

Am J Clin Nutr. 2016 Jan;103(1):66-70. doi: 10.3945/ajcn.115.117440. Epub 2015 Nov 25.

PMID:
26607942
19.

Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.

Hiramatsu T, Ozeki A, Asai K, Saka M, Hobo A, Furuta S.

Ther Apher Dial. 2015 Dec;19(6):598-605. doi: 10.1111/1744-9987.12319. Epub 2015 Nov 11.

PMID:
26556397
20.

[Ketosis prone type 2 diabetes (KPD)].

Concha L L, Durruty A P, García de Los Ríos A M.

Rev Med Chil. 2015 Sep;143(9):1215-8. doi: 10.4067/S0034-98872015000900017. Spanish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk